Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Dreesen

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|June 12, 2026
Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel diseaseSofie De Groote, Karen van Hoeve, Erwin Dreesen, et al.
Alpha Psychiatry|November 10, 2025
High Doses of Antidepressants and Long-term Treatment of Obsessive-compulsive Disorder: Another Barrier to Accessing Deep Brain Stimulation?Emma Verstraete, Erwin Dreesen, Koen Schruers, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2024
Identifying risk factors of anti-TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel diseaseKaren van Hoeve, Debby Thomas, Tom Hillary, et al.
Clinical Pharmacology : Advances and Applications|October 19, 2017
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseasesErwin Dreesen, Peter Bossuyt, Denis Mulleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2023
Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation StudyZhigang Wang, Bram Verstockt, João Sabino, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2024
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across EuropeSilje Skrede, Nataša Bogavac-Stanojević, Erwin Dreesen, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Clinical Pharmacokinetics|May 4, 2026
Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software ToolsNada Dia, Yannick Hoffert, Angela Elma Edwina, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Trends in Pharmacological Sciences|December 4, 2024
Model-informed precision dosing in inflammatory bowel diseasesArno R Bourgonje, Marla C Dubinsky, Ron J Keizer, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Gastroenterology and Nutrition|June 12, 2026
Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel diseaseSofie De Groote, Karen van Hoeve, Erwin Dreesen, et al.
Alpha Psychiatry|November 10, 2025
High Doses of Antidepressants and Long-term Treatment of Obsessive-compulsive Disorder: Another Barrier to Accessing Deep Brain Stimulation?Emma Verstraete, Erwin Dreesen, Koen Schruers, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2024
Identifying risk factors of anti-TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel diseaseKaren van Hoeve, Debby Thomas, Tom Hillary, et al.
Clinical Pharmacology : Advances and Applications|October 19, 2017
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseasesErwin Dreesen, Peter Bossuyt, Denis Mulleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2023
Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation StudyZhigang Wang, Bram Verstockt, João Sabino, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2024
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across EuropeSilje Skrede, Nataša Bogavac-Stanojević, Erwin Dreesen, et al.
Therapeutic Drug Monitoring|July 14, 2017
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in PediatricsSara Murias, Lorena Magallares, Fatima Albizuri, et al.
Clinical Pharmacokinetics|May 4, 2026
Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software ToolsNada Dia, Yannick Hoffert, Angela Elma Edwina, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Trends in Pharmacological Sciences|December 4, 2024
Model-informed precision dosing in inflammatory bowel diseasesArno R Bourgonje, Marla C Dubinsky, Ron J Keizer, et al.
Pageof 11